GST on specified medicinal formulations: reduced tax treatment applies to formulations made from listed bulk drugs. A reduced GST rate applies to pharmaceutical formulations manufactured from the bulk drugs enumerated in List 2 appended to Schedule I, applicable up to 21-09-2025; List 2 identifies twenty-two specified bulk drugs, including streptomycin, isoniazid, ethambutol, pyrazinamide, dapsone, tetracycline hydrochloride, hydrocortisone, chloroquine, quinine and arteether or formulations of artemisinin.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
GST on specified medicinal formulations: reduced tax treatment applies to formulations made from listed bulk drugs.
A reduced GST rate applies to pharmaceutical formulations manufactured from the bulk drugs enumerated in List 2 appended to Schedule I, applicable up to 21-09-2025; List 2 identifies twenty-two specified bulk drugs, including streptomycin, isoniazid, ethambutol, pyrazinamide, dapsone, tetracycline hydrochloride, hydrocortisone, chloroquine, quinine and arteether or formulations of artemisinin.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.